Inventor · disambiguated record
Maxim Tsypin
Also filed as: TSYPIN MAXIM · TSYPIN MAXIM M
20 granted patents·6 pending applications·318 citations·filing 2004–2020
96Inventor score
Top patents by PatentIndex Score
26 records- 0198US7736905B2Method and system for determining whether a drug will be effective on a patient with a diseaseBIODESIX INC·Filed 2006·Granted Jun 15, 2010·72 cites·18 claims
- 0295US7906342B2Monitoring treatment of cancer patients with drugs targeting EGFR pathway using mass spectrometry of patient samplesBIODESIX INC·Filed 2009·Granted Mar 15, 2011·23 cites·3 claims
- 0395US7879620B2Method and system for determining whether a drug will be effective on a patient with a diseaseBIODESIX INC·Filed 2010·Granted Feb 1, 2011·24 cites·8 claims
- 0495US7858389B2Selection of non-small-cell lung cancer patients for treatment with monoclonal antibody drugs targeting EGFR pathwayBIODESIX INC·Filed 2009·Granted Dec 28, 2010·30 cites·4 claims
- 0593US10007766B2Predictive test for melanoma patient benefit from antibody drug blocking ligand activation of the T-cell programmed cell death 1 (PD-1) checkpoint protein and classifier development methodsBIODESIX INC·Filed 2016·Granted Jun 26, 2018·9 cites·8 claims
- 0693US8119417B2Monitoring treatment of head and neck cancer patients with drugs EGFR pathway using mass spectrometry of patient samplesROEDER HEINRICH·Filed 2011·Granted Feb 21, 2012·8 cites·4 claims
- 0793US8119418B2Monitoring treatment of colorectal cancer patients with drugs targeting EGFR pathway using mass spectrometry of patient samplesROEDER HEINRICH·Filed 2011·Granted Feb 21, 2012·8 cites·4 claims
- 0892US9279798B2Deep-MALDI TOF mass spectrometry of complex biological samples, e.g., serum, and uses thereofBIODESIX INC·Filed 2013·Granted Mar 8, 2016·18 cites·21 claims
- 0992US8586379B2Monitoring treatment of colorectal cancer patients with drugs targeting EGFR pathway using mass spectrometry of patient samplesROEDER HEINRICH·Filed 2011·Granted Nov 19, 2013·6 cites·4 claims
- 1092US8586380B2Monitoring treatment of head and neck cancer patients with drugs targeting EGFR pathway using mass spectrometry of patient samplesROEDER HEINRICH·Filed 2011·Granted Nov 19, 2013·6 cites·4 claims
- 1192US8097469B2Method and system for determining whether a drug will be effective on a patient with a diseaseROEDER HEINRICH·Filed 2010·Granted Jan 17, 2012·15 cites·17 claims
- 1292US7858390B2Selection of colorectal cancer patients for treatment with drugs targeting EGFR pathwayBIODESIX INC·Filed 2009·Granted Dec 28, 2010·26 cites·7 claims
- 1390US8467988B1Method and system for validation of mass spectrometer machine performanceROEDER JOANNA·Filed 2013·Granted Jun 18, 2013·18 cites·20 claims
- 1490US7867775B2Selection of head and neck cancer patients for treatment with drugs targeting EGFR pathwayBIODESIX INC·Filed 2009·Granted Jan 11, 2011·21 cites·5 claims
- 1589US9606101B2Deep MALDI TOF mass spectrometry of complex biological samples, e.g., serum, and uses thereofBIODESIX INC·Filed 2015·Granted Mar 28, 2017·7 cites·6 claims
- 1686US9152758B2Method and system for determining whether a drug will be effective on a patient with a diseaseRÖDER HEINRICH·Filed 2011·Granted Oct 6, 2015·7 cites·2 claims
- 1785US10950348B2Predictive test for patient benefit from antibody drug blocking ligand activation of the T-cell programmed cell death 1 (PD-1) checkpoint protein and classifier development methodsBIODESIX INC·Filed 2018·Granted Mar 16, 2021·2 cites·11 claims
- 1885US9824182B2Method and system for determining whether a drug will be effective on a patient with a diseaseRÖDER HEINRICH·Filed 2010·Granted Nov 21, 2017·7 cites·1 claims
- 1981US8024282B2Method for reliable classification of samples in clinical diagnostics using an improved method of classificationBIODESIX INC·Filed 2008·Granted Sep 20, 2011·11 cites·34 claims
- 2070US12230398B2Predictive test for patient benefit from antibody drug blocking ligand activation of the T-cell programmed cell death 1 (PD-1) checkpoint protein and classifier development methodsBIODESIX INC·Filed 2020·Granted Feb 18, 2025·0 cites·7 claims
- 2160US2012191370A1Method and system for determining whether a drug will be effective on a patient with a diseaseRODER HEINRICH·Filed 2012·Application pending·0 cites
- 2257US2014284468A1Cancer patient selection for administration of therapeutic agents using mass spectral analysis of blood-based samplesBIODESIX INC·Filed 2014·Application pending·0 cites
- 2353US2011282588A1Method to automatically identify peaks and monoisotopic peaks in mass spectral data for biomolecular applicationsTSYPIN MAXIM·Filed 2011·Application pending·0 cites
- 2452US2005267689A1Method to automatically identify peak and monoisotopic peaks in mass spectral data for biomolecular applicationsTSYPIN MAXIM·Filed 2004·Application pending·0 cites
- 2550US2011208433A1Cancer patient selection for administration of therapeutic agents using mass spectral analysis of blood-based samplesBIODESIX INC·Filed 2011·Application pending·0 cites
- 2636US2011028825A1Systems and methods for efficient imagingDATAPHYSICS RES INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Maxim Tsypin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →